A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer

Clinical trial NCT01137994 · WITHDRAWN

Trial details

NCT number: NCT01137994
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2011-10-01
Primary completion: 2016-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.